Oxitan 100 Mg Injection

About Oxitan 100 Mg Injection

Oxitan 100 mg Injection contains Oxaliplatin, a chemotherapy drug used to treat certain types of cancer. It is primarily used in the treatment of colorectal cancer, particularly in combination with other chemotherapy agents, and sometimes for other cancers as prescribed by a doctor.

Key Uses:

1. Colorectal Cancer: Oxaliplatin is commonly used as part of chemotherapy regimens like FOLFOX, which combines Oxaliplatin with fluorouracil (5-FU) and leucovorin to treat advanced or metastatic colorectal cancer.
2. Other Cancers: It may also be used to treat other cancers, including gastric cancer (stomach cancer) and some cancers in the ovaries or esophagus.

Mechanism of Action:

Oxaliplatin is a platinum-based chemotherapy drug. It works by forming cross-links in the DNA within cancer cells, which interferes with DNA replication and transcription. This leads to cell death and prevents cancer cells from dividing and growing.

Common Side Effects:

• Peripheral neuropathy: Numbness, tingling, or pain in the hands and feet, especially after exposure to cold (cold-induced neuropathy).
• Nausea and vomiting.
• Fatigue or weakness.
• Diarrhea.
• Hair loss (temporary).
• Low blood counts: Anemia, leukopenia (low white blood cell count), and thrombocytopenia (low platelet count).

Serious Side Effects:

• Severe allergic reactions: Symptoms may include rash, difficulty breathing, and swelling.
• Severe neuropathy: In rare cases, Oxaliplatin can cause more severe nerve damage, which may affect daily activities.
• Liver toxicity: Regular monitoring of liver function is recommended, as Oxaliplatin can impact liver enzymes.

Dosage:

Oxitan 100 mg Injection is typically administered intravenously (IV) in a clinical setting. The dose and frequency of administration depend on the type of cancer being treated, the overall treatment regimen, and the patients response. Oxaliplatin is usually given every 2 weeks or as part of a chemotherapy cycle.

Precautions:

• Neuropathy: Patients should be carefully monitored for signs of neuropathy, and treatment adjustments may be necessary if symptoms worsen.
• Cold sensitivity: Patients should avoid exposure to cold temperatures as Oxaliplatin can cause cold-induced neuropathy.
• Liver and kidney function: Liver and kidney function should be monitored regularly, as Oxaliplatin can affect these organs.
• Pregnancy and breastfeeding: Oxaliplatin is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus or infant.

Summary:

Oxitan 100 mg Injection is a chemotherapy drug used in the treatment of colorectal cancer and other cancers. It works by damaging the DNA of cancer cells, preventing their growth and spread. While it can be effective, it can cause side effects like peripheral neuropathy, nausea, and low blood counts. Patients receiving Oxaliplatin should be closely monitored by their healthcare provider to manage side effects and adjust treatment as necessary.

About Oxitan 100 Mg Injection

Oxitan 100 Mg Injection is a cytotoxic chemotherapy medication containing oxaliplatin, a platinum-based agent specifically designed for intravenous use in the treatment of colorectal cancer. This sterile, single-dose solution comes in a glass vial, ideal for use in hospitals and clinics. It should only be used as directed by a physician and is not suitable for mixing with sodium chloride or alkaline solutions.


Dosage and Administration

Oxitan must be administered via intravenous infusion by a healthcare professional and is suitable for single use only. The frequency and dosage depend on the physician's prescription and individual patient requirements. Any unused medication should be discarded immediately after administration.


Safe Handling and Storage

Store Oxitan vials below 30C and protect them from light to maintain integrity. The product is packaged in a preservative-free, sterile vial, and should be handled according to standard cytotoxic safety protocols. Never reuse vials, and always follow the disposal guidelines for cytotoxic agents.